BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20846257)

  • 1. Comparative study between oral and sublingual 600 µg misoprostol for the treatment of incomplete abortion.
    Paritakul P; Phupong V
    J Obstet Gynaecol Res; 2010 Oct; 36(5):978-83. PubMed ID: 20846257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial.
    Diop A; Raghavan S; Rakotovao JP; Comendant R; Blumenthal PD; Winikoff B
    Contraception; 2009 Jun; 79(6):456-62. PubMed ID: 19442782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study between single dose 600 microg and repeated dose of oral misoprostol for treatment of incomplete abortion.
    Phupong V; Taneepanichskul S; Kriengsinyot R; Sriyirojana N; Blanchard K; Winikoff B
    Contraception; 2004 Oct; 70(4):307-11. PubMed ID: 15451335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial.
    Ayudhaya OP; Herabutya Y; Chanrachakul B; Ayuthaya NI; O-Prasertsawat P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S5-10. PubMed ID: 17726806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
    Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
    J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual versus vaginal misoprostol for the management of missed abortion.
    Tanha FD; Feizi M; Shariat M
    J Obstet Gynaecol Res; 2010 Jun; 36(3):525-32. PubMed ID: 20598032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two regimens of misoprostol for treatment of incomplete abortion.
    Blanchard K; Taneepanichskul S; Kiriwat O; Sirimai K; Svirirojana N; Mavimbela N; Winikoff B
    Obstet Gynecol; 2004 May; 103(5 Pt 1):860-5. PubMed ID: 15121557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Nguyen TM; Marions L; Okoev G; Khomassuridze A; Kereszturi A; Mittal S; Nair R; Daver R; Pretnar-Darovec A; Dickson K; Nguyen DH; Nguyen HB; Hoang TD; Peregoudov A;
    Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of 3 misoprostol protocols for abortion induction at 13-20 weeks of gestation.
    Caliskan E; Dilbaz S; Doger E; Ozeren S; Dilbaz B
    J Reprod Med; 2005 Mar; 50(3):173-80. PubMed ID: 15841929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortion.
    Nguyen TN; Blum J; Durocher J; Quan TT; Winikoff B
    Contraception; 2005 Dec; 72(6):438-42. PubMed ID: 16307967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
    Tang OS; Chan CC; Kan AS; Ho PC
    Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual versus oral misoprostol for uterine evacuation following early pregnancy failure.
    Kushwah B; Singh A
    Int J Gynaecol Obstet; 2009 Jul; 106(1):43-5. PubMed ID: 19426973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of vaginal misoprostol 800 microg versus 400 microg for anembryonic pregnancy: a randomized comparative trial.
    Srikhao N; Tannirandorn Y
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S41-7. PubMed ID: 17722316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.